E-Pill Site Planned

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.


The U.S. arm of British drug maker AstraZeneca PLC and ePhysician Inc. are expected to announce today a three-year agreement to promote the use of ePhysician’s electronic prescription-writing systems to doctors, Tuesday’s Wall Street Journal reported.

AstraZeneca Pharmaceuticals LP (AZN) will provide at least 500 physicians with hand-held devices that run ePhysician, and cover the system’s monthly fee of about $40, said Stuart Weisman, chief executive of closely held ePhysician, Mountain View, Calif.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in